Abstract
Background
An insight into the utilization pattern helps in future planning of blood drive. This study was conducted to describe the demographic characteristics of the transfusion recipients and pattern of blood and blood product utilization in Nigeria.
Methods
Blood bank registers of University of Calabar Teaching Hospital (UCTH) Calabar were analysed for a 12 month period. Number of blood units requested, number of units issued, Cross-match to transfusion ratio (C/T), age, gender, blood group, blood components received, patients ward and clinical diagnosis were computed. Diagnoses were grouped into broad categories according to the disease headings of International Classification of Diseases (ICD-10).
Results
Majority of the 2336 transfusion recipients studied were females (69.09%) and are in the reproductive age group; 15–49 years (75.23%). The median age of the recipients was 35 years (range, 0–89). Most of the recipients (n = 1636; 70.04%) received whole blood transfusion. Majority (94.46%) of the cross–matched units were issued giving C/T ratio of 1.06. The common blood group type was O Rhesus positive (62.63%). Obstetrics and Gynecology had the highest blood requisition (41.40%). The majority of the patients were diagnosed with conditions related to pregnancy and childbirth (38.70%), conditions originating in prenatal period (14.38%). The age range of 25–54 years had the highest blood transfusion requests (n = 501; 51.07%), of these, females were majority (n = 390;77.84%).
Conclusions
Our study recorded mostly young patients who received mostly whole blood. Most of the patients in the reproductive age group received transfusion for pregnancy and child-birth related cases.
Keywords: Transfusion, Blood utilization, Blood usage, Whole blood, International classification of disease (ICD)
Background
Blood transfusion plays important role in medical and surgical practice [1]. In order to achieve these, critical review and continuous evaluation of the use of blood and its components becomes essential [2]. These entails studying the pattern of blood components use, the clinical conditions and wards requiring blood transfusion, the risks associated with blood transfusion and the demographic characteristics of the blood transfusion recipients in a population. Evaluation of blood requisition and utilization is essential in assessing the present and future demands for blood and avoiding unnecessary requests and transfusions [3]. Despite the development of national blood service policy [4], most medical facilities in Nigeria still find it difficult in establishing viable and efficient blood banking system [5]. On this premise, it becomes necessary to ensure judicious utilization of this scarce commodity. Data on blood utilization is helpful in resource limited settings in which there is always competing needs for scarce resources [6]. Information on blood utilization will assist in establishing clinical practice guidelines, strategizing on new donor recruitment, streamlining resources for the therapeutic benefit of the patient [3, 7] and conducting cost effective analysis [8]. Various studies have shown variable distribution in demand for blood and its components [9, 10], but none has looked into the variability in the blood use based on diseased classification (1CD-10) as well as blood group type of the recipients. Hence, this study sets off to establish local use pattern of blood and blood product to aid in effective management of patient need.
Methods
Study setting
This study was conducted in the blood bank unit of the Hematology Department of University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria which happens to be the only tertiary institution in the state.
Study design
This study employed retrospective analysis of blood transfusion recipients’ data covering all blood and blood components transfused within the period from March 2016 to February, 2017.
Data collection
Data were collected retrospectively from the register of the blood bank for the 12 months period from March 2016 to February 2017 and covered all blood and blood components recorded in the blood bank during this period. Cross-match and issue registers were accessed to retrieve the required information such as gender, age, blood group, product requested, ward and clinical diagnosis.
Statistical analysis
The data collected were analyzed using SPSS version 20 software (Armonk, NY. IBM Corp.). Frequency and percentages were used to summarize categorical demographic and clinical variables.
Result
A total of 2473 units were requested within the study period consisting of 1770 whole blood, 468 packed cells and 235 plasma. About 94.46% (2336) of the cross matched requests were issued consisting of 1636 (70.04%) whole blood, 467 packed cells (19.99%) and 233 (9.97%) plasma resulting in a cross match to transfusion (C/T) ratio of 1.06 (Table 1).
Table 1.
Blood component | Units cross matched | Units issued | C/T Ratio | ||
---|---|---|---|---|---|
N | (%) | N | (%) | ||
Whole blood | 1770 | (71.57) | 1636 | (70.04) | 1.08 |
Packed cell | 468 | (18.93) | 467 | (19.99) | 1.00 |
Plasma | 235 | (9.50) | 233 | (9.97) | 1.01 |
Total | 2473 | (100.00) | 2336 | (100.00) | 1.06 |
C/T ration cross-match to transfusion ratio, % percentage, N absolute number
Most transfusion recipients were female (1614; 69.09%) of whom 475 (29.43%) were in the reproductive age group (15–49 years). Approximately 20% of the transfusion recipients were under the age of 15 while 7% were at least 65 years (Table 2).
Table 2.
Age range (years) | Recipient | Males | Females | |||
---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | |
0–14 | 197 | (20.08) | 106 | (58.81) | 91 | (46.19) |
15–24 | 123 | (12.54) | 38 | (30.89) | 85 | (69.11) |
25–54 | 501 | (51.07) | 111 | (22.16) | 390 | (77.84) |
55–64 | 91 | (9.28) | 52 | (57.14) | 39 | (42.86) |
65+ | 69 | (7.03) | 43 | (62.32) | 26 | (37.68) |
Not recorded | 1355 | 372 | 912 | |||
Total | 2336 | 722 | 1614 |
N absolute number of subjects, % percentage
Table percentages, exclude non recorded values
The most common blood group type observed in the blood/blood component recipients was O Rhesus Positive (1463; 62.63%) while the least was AB Rhesus Negative (0; 0%) (Table 3).
Table 3.
Blood group | Recipient | Males | Females | |||
---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | |
A+ | 463 | (19.82) | 159 | (34.34) | 304 | (65.66) |
A− | 47 | (2.01) | 16 | (34.04) | 31 | (65.96) |
AB+ | 4 | (0.17) | 2 | (50.00) | 2 | (50.00) |
AB− | 0 | (0.00) | 0 | (0.00) | 0 | (0.00) |
B+ | 274 | (11.73) | 73 | (26.64) | 201 | (73.36) |
B− | 19 | (0.81) | 11 | (57.89) | 8 | (42.11) |
O+ | 1463 | (62.63) | 442 | (30.21) | 1021 | (69.79) |
O− | 66 | (2.83) | 19 | (28.79) | 47 | (71.21) |
Total | 2336 | (100.00) | 722 | (30.91) | 1614 | (69.09) |
N absolute number of subjects, % percentage
The top six broad 1CD-10 diagnosis categories accounting for most blood transfusion recipients were pregnancy and child birth (n = 904; 38.70%), condition originating in perinatal period (n = 336; 14.38%), diseases of the genitourinary system (n = 184; 7.88%), diseases of the blood and blood forming organs (n = 182; 7.79%), Neoplasm (n = 156; 6.68%) and injury and poison (n = 102; 4. 37%) (Table 4).
Table 4.
Diagnostic category (ICD-10 code) | Recipients | |
---|---|---|
N | (%) | |
Infectious and parasitic diseases | 78 | (3.34) |
Neoplasms | 156 | (6.68) |
Disease of blood & blood forming organs | 182 | (7.79) |
Endocrine, nutritional & metabolic diseases | 26 | (1.11) |
Mental and behavioral disorders | 0 | (0.00) |
Diseases of the nervous system | 8 | (0.34) |
Eye and adnexa diseases | 6 | (026) |
Ear and adnexa diseases | 2 | (0.09) |
Circulatory system diseases | 76 | (3.25) |
Respiratory system diseases | 22 | (0.94) |
Digestive system diseases | 92 | (3.94) |
Skin and subcutaneous tissue diseases | 14 | (0.60) |
Musculoskeletal system & connective tissue diseases | 44 | (1.88) |
Genitourinary system diseases | 184 | (7.88) |
Pregnancy, childbirth & puerperium | 904 | (38.70) |
Condition originating in the perinatal period | 336 | (14.38) |
Congenital malformations | 34 | (1.46) |
Symptoms, signs and abnormal clinical and laboratory findings | 62 | (2.65) |
Injury and poison | 102 | (4.37) |
External causes of morbidity | 8 | (0.34) |
Total | 2336 | (100.00) |
ICD International classification of diseases
n absolute number, % percentage
Obstetrics and Gynecology ward had the highest (967; 41.40%) blood recipients while Eye and Dental/MFU had the least (5; 0.21%) (Table 5).
Table 5.
Ward | Recipients | |
---|---|---|
N | (%) | |
Medical | 378 | (16.18) |
Orthopedic | 114 | (4.88) |
Cardiothoracic | 12 | (0.15) |
Surgical | 198 | (8.48) |
ENT | 18 | (0.78) |
Eye | 5 | (0.21) |
O & G | 967 | (41.40) |
Pediatrics | 22 | (0.94) |
SCBC | 55 | (2.35) |
ICU | 21 | (0.90) |
CHER | 101 | (4.32) |
Casualty | 375 | (16.05) |
HDCU | 65 | (2.78) |
Dental/MFU | 5 | (0.21) |
Total | 2336 | (100.00) |
ENT Ear, Nose and Throat, O and G Obstetrics and Gynecology, SCBU Special care baby unit, ICU intensive care unit, CHER children Emergency Room, HDCU Haematology Day Care unit, MFU Maxillofacial unit
A category of the transfusion recipients based on the four broad category showed that more blood requisition in Obstetrics and gynecology (n = 967; 41.40%) while the least was pediatrics (n = 178; 7.62) (Table 6).
Table 6.
Broad Hospital section | Recipient | |
---|---|---|
N | (%) | |
Pediatrics | 178 | 7.62 |
Surgery | 317 | 13.57 |
O & G | 967 | 41.40 |
Medicine | 874 | 37.41 |
Further stratification of blood components showed that whole blood was utilized more (n = 947; 57.89%) in obstetrics and gynecology, while packed cells and plasma were utilized more (n = 374; 80.09% and n = 188; 80.69%, respectively) in medicine (Table 7).
Table 7.
Broad Hospital section | Blood component | ||
---|---|---|---|
Whole blood (%) | Packed cell (%) | Plasma (%) | |
Pediatrics | 82 (5.01) | 71 (15.20) | 25 (10.73) |
Surgery | 295 (18.03) | 8 (1.71) | 14 (6.01) |
O & G | 947 (57.89) | 14 (3.00) | 6 (2.57) |
Medicine | 312 (19.09) | 374 (80.09) | 188 (80.69) |
Discussion
This study provided information on the pattern of blood and blood components utilization and demographic characteristics of blood transfusion recipients in University of Calabar Teaching Hospital, Nigeria.
This study comprised much of younger cohort of transfusion recipients. This observation is similar to the report of a study in Zimbabwe [6] but in contrast with studies reported from developed countries in which majority of the transfusion recipients were above the age of 60 years [8, 10, 11]. This low median age reflects the age trend of the Nigerian population which comprised mainly of young people with only 3.12% being above the age of 65 years [12]. The life expectancy at birth for Nigeria is currently estimated at 54 years whereas the global population average is 70 years [13]. Developed countries are mainly characterized by ageing population owing to higher mean life expectancies.
This study recorded greater number of female transfusion recipients. Blood transfusion recipients in sub-Saharan Africa are mostly children in malaria endemic areas, and women of childbearing age due to complications of labour [14, 15]. Women, especially the childbearing age group (15–49 years) received the majority of the blood and blood components transfused. This observation is in consonance with findings in other countries in sub-Saharan Africa where women receive more blood for pregnancy-related complications consequent to intra-partum and post-partum hemorrhage [15, 16]. In contrast, studies from developed countries reported that more men than women receive blood transfusion [8, 17]. This may be attributed to advanced health care services which reduced the associated complications of child bearing requiring transfusion [6].
Majority of the transfusion recipients in this study (71.57%) received whole blood transfusion. This is consistent with earlier study in Jigawa Nigeria [18] which reported 87.3%. This is a reflection of common practice of requesting for whole blood in resource limited settings owing to non-availability of facilities to practice component separation. In standard practice, whole blood is only issued for transfusion following cases of massive hemorrhages and exchange transfusion.
This study recorded an average C/T ration of 1.06 which is an indication of effective and efficient utilization of blood and blood products. This finding is similar to 0.9 reported in Ibadan Nigeria [19] but lower than 2.2 reported in Ibadan, Nigeria [20]. The observed differences may be due to the varying levels of availability of blood and indications for blood transfusion as judged by the requesting physician [19, 20].
The top six diagnoses for which patients received blood transfusion in this study were pregnancy and childbirth, conditions originating in perinatal period, diseases of the genitourinary system, diseases of blood and blood forming organs, neoplasm and injury and poison. This finding is similar to earlier report in Zimbabwe [6] with conditions originating in perinatal period being replaced by infections and parasitic diseases. However, other studies in Nigeria did not classify diagnosis according to ICD-10 making direct comparisons with the findings of this study impossible. Studies from non-African decent reported neoplasms, injury and poison, digestive system diseases and circulatory system diseases as the main diagnosis associated with transfusion [21, 22]. This strongly portrays that blood utilization pattern vary significantly within regions and according to practice as well as patients clinical findings. More so, diseases burden, level of organization and advancement of healthcare in the different settings also contribute to the significant differences in blood utilization [6].
The obstetrics and Gynecology ward had the highest blood requisition (41.40%). This finding is similar to previous reports [18, 23]. This observation may be related to the fact that most obstetric and gynecological events may be bleeding related. Peri-partum hemorrhage has been reported as common indication for blood transfusion in obstetric events [24]. More so, the fact that majority of the subjects were females of child bearing age contributed to this outlying peak. Further classification of the blood transfusion recipients based on the four broad classification showed obstetrics still had the highest requisition (41.40%) while pediatrics had the least (7.62%). This finding is similar to previous report by Musa et al. [9] who reported 42.79 and 11.67%, respectively in a study in Zaria, Nigeria. However, their study made 6 broad classification; splitting some areas of internal medicine into trauma and emergency.
Whole blood was mostly used by obstetrics and gynecology while packed cells and plasma were mostly used in medicine. Ideally, blood is effectively used by processing it into components such as red cell concentrates, platelet concentrates, plasma (fresh frozen plasma) and cryoprecipitate [25], but lack of facility for component separation as in our institution makes such difficult. Published guidelines based on “expert opinion” recommends transfusion of plasma for the following clinical indications: active bleeding in the setting of multiple coagulation factor deficiencies (massive transfusions, disseminated intravascular coagulation); emergency reversal of warfarin in patients with active bleeding in settings where prothrombin complex concentration with adequate level of factor VII is not available; and for use as replacement when performing plasma exchange [26–30]. Specifically, these are seen in burns [31, 32], oncology [33], obstetric events [34–36], and more. Packed red cells are indicated in conditions requiring prevention of anemia related tissue hypoxia [37]. Indications for packed cell transfusion include acute sickle cell crisis (for prevention of stroke), acute blood loss greater than 1500 mL or 30% of blood volume [38].
The distribution of ABO blood groups among blood recipients in this study is consistent with that reported in donor population in Nigeria [39]. Acute blood shortage of specific group is a common event in Nigerian hospitals, hence making an understanding of the distribution of blood groups among transfusion recipients important. This information is essential in planning for blood drive as well as distribution of blood and blood components; subsequently ensuring that patients receive blood matching their ABO blood group and Rhesus type [6]. Of the 33 blood group systems representing over 300 antigens as listed by International Society of Blood Transfusion, ABO and Rhesus blood groups are the first two most clinically important blood groups [40, 41].
This study has a number of potential limitations. However, this study was carried out in a major tertiary health institution in Calabar, Nigeria, but the extrapolation of the entire findings of this study to Nigeria may need some caution. More so, this study made the assumption that issued blood units were transfused.
Conclusion
This study recorded greater number of women receiving blood and blood product transfusion for conditions associated with pregnancy and childbirth. The blood recipients were mostly young patients of reproductive age group. We found that the most indications for blood transfusion based on ICD-10 were pregnancy and child birth, conditions originating in perinatal period, diseases of genitourinary system and diseases of blood and blood forming organs. Whole blood was the major blood component recorded in this study. This shows a lag in healthcare improvement and unnecessary waste of blood. Although this study was based on a single blood bank, the findings provided an insight into the characteristics of blood transfusion recipients and as well aid in future planning of better blood and blood product utilization.
Acknowledgments
Availability of data and material
The datasets supporting the finding of this study is available from the corresponding author on reasonable request.
Funding
No external funding was received for this study.
Abbreviations
- C/T
Cross match to transfusion ratio
- CHER
Children Emergency Room
- ENT
Ear, Nose and Throat
- HDCU
Haematology Day Care Unit
- HREC
Health Research Ethical Committee
- ICD
International Classification of Disease
- ICU
Intensive Care Unit
- MFU
Maxillofacial Unit
- O & G
Obstetrics and Gynecology
- SCBC
Special Care Baby Unit
- UCTH
University of Calabar Teaching Hospital
Authors’ contributions
HUO conceived and designed the study. HUO and IMO analysed and interpreted the data. HUO drafted the initial manuscript. IMO reviewed the manuscript. Both authors read and approved the final manuscript.
Competing interest
The authors declare they have no competing interest.
Ethics approval and consent to participate
This study was approved by Health Research Ethical Committee (HREC) of the University of Calabar Teaching Hospital. As only secondary data was used in this study, consent to participate was not required following HREC guidelines.
Consent for publication
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Henshaw Uchechi Okoroiwu, Phone: +234 8038833901, Email: okoroiwuhenshaw@gmail.com.
Ifeyinwa Maryann Okafor, Email: okaforify12@gmail.com.
References
- 1.Outta AB. Blood banking and transfusion. 1. New Delhi: CBS Publishers; 2006. Transfusion practice clinical aspects and application; pp. 213–321. [Google Scholar]
- 2.Lim YA, Lee WG, Chow SR, et al. A study of blood usage by diagnosis in a Korean University hospital. Vox Sang. 2004;86:54–61. doi: 10.1111/j.0042-9007.2004.00385.x. [DOI] [PubMed] [Google Scholar]
- 3.Zimmermann R, Buscher M, Linhardt C, et al. A survey of blood component use in a German University hospital. Transfusion. 1997;37:1075–1083. doi: 10.1046/j.1537-2995.1997.371098016449.x. [DOI] [PubMed] [Google Scholar]
- 4.National Blood Transfusion Service . Federal Ministry of Health [Nigeria]. The National Blood Policy. Abuja: National Blood Transfusion Service, Federal Ministry of Health. National Blood Transfusion Service, Federal Ministry of Health: Abuja; 2006. [Google Scholar]
- 5.Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645. 10.1186/s12889-018-5555-x [DOI] [PMC free article] [PubMed]
- 6.Nyashadzaishe M, Star K, Oliver H, Brian EF, Isaac K, et al. Profile of blood and blood component transfusion recipients in Zimbabwe. Blood Transfus. 2015;13:600–609. doi: 10.2450/2015.0019-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Biggin K, Warner P, Prescott R, et al. A review of methods used in comprehensive, descriptive studies that relate to red blood cell transfusion to clinical data. Transfusion. 2010;50:711–718. doi: 10.1111/j.1537-2995.2009.02459.x. [DOI] [PubMed] [Google Scholar]
- 8.Borkent-Raven BA, Janssen MP, Van der Poel CL, et al. The PROTON study; profiles of blood products transfusion recipients in the Netherlands. Vox Sang. 2010;99:54–64. doi: 10.1111/j.1423-0410.2010.01312.x. [DOI] [PubMed] [Google Scholar]
- 9.Musa AU, Ndakotsu MA, Hassan A, Klish A, Kwaifa IK. Pattern of blood transfusion request and utilization at a Nigerian University teaching hospital. Sahel Med J. 2014;171:19–22. doi: 10.4103/1118-8561.129149. [DOI] [Google Scholar]
- 10.Wells AW, Llewelyn CA, Casbard A, et al. The EASTER study; indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the national blood service. Transfus Med. 2009;19:315–328. doi: 10.1111/j.1365-3148.2009.00933.x. [DOI] [PubMed] [Google Scholar]
- 11.Vamvakas EC, Taswell HF. Epidemiology of blood transfusion. Transfusion. 1994;34(6):464–470. doi: 10.1046/j.1537-2995.1994.34694295059.x. [DOI] [PubMed] [Google Scholar]
- 12.CIA. The world factbook. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ni.html. Accessed in 27 Aug 2017.
- 13.World Health Organization. Life Expectancy. Available from: http://www.who.int/gho/mortality_burden_disease/life_tables/en/. Accessed in 27 Aug 2017.
- 14.Schneider WH. History of blood transfusion in sub-saharan Africa. Transfus Med Rev. 2013;27:21–28. doi: 10.1016/j.tmrv.2012.08.001. [DOI] [PubMed] [Google Scholar]
- 15.Bugge HF, Karlsen NC, Oydna E, Rake MM, Wexels M, Bendabenda J, et al. A study of blood transfusion services at a district hospital in Malawi. Vox Sang. 2013;104(1):37–45. doi: 10.1111/j.1423-0410.2012.01628.x. [DOI] [PubMed] [Google Scholar]
- 16.Natukunda B, Schonewille H, Smit-sibinga CT. Assessment of the clinical transfusion practice of a regional referral hospital in Uganda. Transfus Med. 2010;20:134–139. doi: 10.1111/j.1365-3148.2010.00992.x. [DOI] [PubMed] [Google Scholar]
- 17.Geiβler RG, Franz D, Buddendick H, Krakowitzky P, Bunzemeier H, Roeder N, et al. Retrospective analysis of the blood component utilization in a university hospital of maximum medical care. Transfus Med Hemother. 2012;39(2):129–138. doi: 10.1159/000337956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Aliyu I, Michael G, Ibrahim H, Ibrahim ZF, Aliyu G, Isaiah AT. Blood transfusion request pattern in a medical Centre in northwestern Nigeria. Glob J Transfus Med. 2017;2(1):52–55. doi: 10.4103/GJTM.GJTM_51_16. [DOI] [Google Scholar]
- 19.Fasola FA, Kotila RA, Shokunbi WA. Audit of red cell units supply of a busy hospital blood bank in Nigeria. Niger J Clin Pract. 2009;12:165–168. [PubMed] [Google Scholar]
- 20.Ebose EM, Osalumese IC. Blood shortage cituation: an audit of red blood cell order and pattern of utilization. Afr J Biotechnol. 2009;8:5922–5925. doi: 10.5897/AJB09.879. [DOI] [Google Scholar]
- 21.Malthoulin-Pelissier S, Salmi LR, Verret C, Demoures B. Blood transfusion in a random sample of hospitals in France. Transfusion. 2000;40(9):1140–1146. doi: 10.1046/j.1537-2995.2000.40091140.x. [DOI] [PubMed] [Google Scholar]
- 22.Goncalez TT, Sabino EC, Capuani L, Capuani L, Liu J, Wright DJ, et al. Blood transfusion utilization and recipient survival at hospital das clinicas in Sao Paulo, Brazil. Transfusion. 2012;52(4):729–738. doi: 10.1111/j.1537-2995.2011.03387.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kagu MB, Ahmed SG, Askira BH. Utilization of blood transfusion service in north eastern Nigeria. Highland Med Res J. 2007;5(2):27–30. [Google Scholar]
- 24.Osei EN, Odoi AT, Owusu-Ofori S, Allan JP. Appropriateness of blood product transfusion in the obstetrics and gynecology (O&G) department of a tertiary hospital in West Africa. Transfus Med. 2013;23(3):160–166. doi: 10.1111/tme.12028. [DOI] [PubMed] [Google Scholar]
- 25.World Health Organization (WHO). Blood safety and availability. 2017. Available at: http://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability. Accessed 25 June 2018.
- 26.O’Shaughnessy DF, Atterbury C, Bolton MP, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Hematol. 2004;126(1):11–28. doi: 10.1111/j.1365-2141.2004.04972.x. [DOI] [PubMed] [Google Scholar]
- 27.Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guideline for plasma transfusion. Transfusion. 2010;50(6):1227–1239. doi: 10.1111/j.1537-2995.2010.02632.x. [DOI] [PubMed] [Google Scholar]
- 28.Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis Applcation Committee of the American Society for apheresis. J Clin Apher. 2010;25(3):83–117. doi: 10.1002/jca.20240. [DOI] [PubMed] [Google Scholar]
- 29.Society of Thoracic Surgeons Task Force. Ferraris VA, Brown JR, et al. 2011 update to the Society of Thoracic Surgeons and Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–982. doi: 10.1016/j.athoracsur.2010.11.078. [DOI] [PubMed] [Google Scholar]
- 30.Yang L, Stanworth S, Hoewell S, Doree C, Murphy M. Is fresh froze plasma clinically effective? An update of a systematic review of randomized controlled trial. Transfusion. 2012;52(8):1673–1686. doi: 10.1111/j.1537-2995.2011.03515.x. [DOI] [PubMed] [Google Scholar]
- 31.Lu RP, Lin F, Ortiz-Pujols SM, Adams SD, Whinna HC, Carns BA, Key NS. Blood utilization in patients with burn injury and associated with clinical outcomes. Transfusion. 2013;53(10):2212–2221. doi: 10.1111/trf.12057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Jones LM, Brown N, Philips G, Blay BA, Bhatti P, Miller SF, Coffey R. Burn resuscitation with fresh froze plasma: 5 years of experience with the west Penn formula. Austn J Emerg Crit Care Med. 2015;2(2):1018. [Google Scholar]
- 33.Federici AB, Vanelli C, Arrigoni L. Transfusion issues in cancer patients. Thromb Res. 2012;129(Suppl1):S60–S65. doi: 10.1016/S0049-3848(12)70018-X. [DOI] [PubMed] [Google Scholar]
- 34.Cata JP, Gottumkkala V. Blood transfusion practices in cancer surgery. Indian J Anaesth. 2014;58(5):637–642. doi: 10.4103/0019-5049.144675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gupte SC, Patel PN. Blood transfusion practice in obstetrics and gynecology: impact of educational programs to create awareness for judicious use of blood components. Indan J Hematol Blood Transfus. 2014;30(3):175–179. doi: 10.1007/s12288-013-0229-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chhabra S, Namgyal A. Rationale use of blood and its components in obstetric-gynecological practice. J Mahatma Ghandi Inst Med Sci. 2014;9(2):93–99. doi: 10.4103/0971-9903.138427. [DOI] [Google Scholar]
- 37.Muller MM, Geisen C, Seifried E. Transfusion of packed red cells. Dtsch Arztebl Int. 2015;112(29–30):507–518. doi: 10.3238/arztebl.2015.0507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Klein HG, Spahn DR, Carso JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370(9585):415–426. doi: 10.1016/S0140-6736(07)61197-0. [DOI] [PubMed] [Google Scholar]
- 39.Mathew EE, Godwin NB. Distribution of ABO and rhesus-D blood groups in the Benin area of Niger Delta: implication for general blood transfusion. Asian J Transfus Sci. 2008;2(1):3–5. doi: 10.4103/0973-6247.39502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Logdberg L, Reid ME, Lamont RE, Zelinski T. Human blood group genes 2004: chromosomal locations and cloning strategies. Transfus Med Rev. 2005;19:45–57. doi: 10.1016/j.tmrv.2004.09.007. [DOI] [PubMed] [Google Scholar]
- 41.Logdberg L, Reid ME, Zelinski T. Human blood group genes 2010: chromosomal locations and cloning strategies revisited. Transfus Med Rev. 2011;25:36–46. doi: 10.1016/j.tmrv.2010.08.005. [DOI] [PubMed] [Google Scholar]